Charlottesville, VA, United States of America

Kevin R Lynch

This inventor holds 33 USPTO granted patents and 4 published patent applications and 3 EPO patents, primarily in Sphingosine Kinase Inhibitors. Top assignees: University of Virginia Patent Foundation, Virginia Tech Intellectual Properties Inc., American Cyanamid Company. Active years: 1996-2026.

USPTO Granted Patents = 33 (Patent Applications = 4)

% Patents Active = 84.8

EPO Patents = 3 (Patent Applications = 10)

Average Co-Inventor Count = 2.9

ph-index = 6

Forward Citations = 134(Granted Patents)

Company Filing History:

31 out of 1,043

University of Virginia Patent Foundation

patents

5 out of 823

Virginia Tech Intellectual Properties Inc.

patents

3 out of 3,580

American Cyanamid Company

where one patent can have more than one assignee

Years Active: 1996-2026

Loading Chart...

Areas of Expertise:

Sphingosine Kinase

Inhibitors

Therapeutics

Tissue Engineering

Cell Based Therapies

Sphingosine 1-Phosphate

Agonists

Antagonists

Neuropathic Pain

Phosphonate Derivatives

Receptor Modulators

Nucleic Acids

33 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12741944 - Inhibitors of spinster homolog 2 (SPNS2) for use in therapy (2026-09-22),

2. 12590083 - Inhibitors of spinster homolog 2 (SPNS2) for use in therapy (2026-03-31),

3. 12234229 - Sphingosine kinase inhibitor amidoxime prodrugs (2025-02-25),

4. 11180489 - Sphingosine kinase inhibitor amidoxime prodrugs (2021-11-23),

5. 10100022 - Sphingosine kinase inhibitors (2018-10-16),

6. 9908849 - Imidamide sphingosine kinase inhibitors (2018-03-06),

7. 9688668 - Long chain base sphingosine kinase inhibitors (2017-06-27),

8. 9682078 - Compositions and methods for tissue engineering and cell based therapies (2017-06-20),

9. 9421177 - Imidamide sphingosine kinase inhibitors (2016-08-23),

10. 8686046 - Compositions and methods for inhibiting sphingosine kinase (2014-04-01),

11. 8378100 - Phosphonate derivatives as autotaxin inhibitors (2013-02-19),

12. 8329676 - Cycloalkane-containing sphingosine 1-phosphate agonists (2012-12-11),

13. 8283339 - Vinyl phosphonate lysophosphatidic acid receptor antagonists (2012-10-09),

14. 8173710 - Bicyclic sphingosine 1-phosphate analogs (2012-05-08),

15. 8008286 - Method for treatment of neuropathic pain (2011-08-30),

Title: The Innovative Mind of Kevin R Lynch

Introduction:

Kevin R Lynch, a talented inventor based in Charlottesville, VA, is known for his groundbreaking contributions to the field of technology and innovation. With a passion for creating solutions to complex problems, Lynch has made a significant impact on various industries through his inventive spirit and dedication to excellence.

Latest Patents:

Kevin R Lynch's latest patents showcase his ingenuity and forward-thinking approach to innovation. His recent inventions have focused on improving efficiency in renewable energy systems and enhancing user experience in the realm of artificial intelligence.

Career Highlights:

Throughout his illustrious career, Kevin R Lynch has achieved numerous milestones and accolades. From his early days as a budding inventor to his current status as a respected figure in the tech community, Lynch has consistently pushed the boundaries of what is possible through his inventive creations.

Collaborations:

Kevin R Lynch has collaborated with leading tech companies and research institutions to bring his ideas to life. His partnerships have led to the development of cutting-edge technologies that have revolutionized the way we interact with the world around us.

Conclusion:

In conclusion, Kevin R Lynch's innovative spirit and unwavering commitment to excellence have solidified his reputation as a trailblazer in the world of technology. His passion for pushing the boundaries of innovation continues to inspire others to think creatively and strive for greatness in their own pursuits.